S
udden cardiac death (SCD) is one of the largest causes of mortality and health care utilization in the world and, for many victims, their first and last contact with the health care system. Sudden cardiac arrest (SCA) affects 150,000 to 450,000 individuals per year in the United States alone (1), most of whom would not be considered at high risk a priori (2) , of whom approximately 90% experience SCD (i.e., about 10% survive SCA) (3) . The causes for SCA are imprecisely defined, and evolving. Most cases still reflect ventricular arrhythmias, although increasing numbers reflect bradycardia and pulseless electrical activity (2) , which have lower survival (4, 5) . It is unclear whether this reflects trends for reduced mortality from coronary disease (4, 5) , but such trends have been more modest in SCA (2) despite advances in basic, translational, and population science.
This state-of-the-art review identifies knowledge gaps in SCA, focused on unique avenues for therapy.
We recognize the enormous strides made by past and current investigators but also the substantial challenges ahead. A central theme is the need for a broader taxonomy that recognizes SCA, not as a disease entity, but as the terminal event of several processes not limited to cardiovascular pathology ( Figure 1 ). Current guidelines for SCA (6) identify patients mostly with cardiac phenotypes (7), yet noncardiac comorbidities worsen outcome (8) , and most victims have undefined pathology (9, 10) . Classifying SCA by organ-system comorbidities may also foster interdisciplinary science and technology innovation. The second theme is creation of a digital infrastructure (Central Illustration) to translate scientific knowledge between multiple diverse specialty groups into unified management strategies for SCA.
The digital network could use continuous biometric data and analytical tools including machine learning to better identify at-risk phenotypes, use these data and online platforms (11) to create actionable registries for allocating resources, then apply ubiquitous GPS devices to coordinate first response and emergency medical services (EMS) and advance resuscitation. Patient outcomes could then be used to reinforce or revise the network as appropriate. Such a framework may require substantial and novel publicprivate collaborations and funding initiatives.
The document is structured around 3 key concepts: respond, understand and predict, and prevent sudden cardiac arrest.
RESPOND
Despite our best efforts, <20% of victims of out-of-hospital SCA have restoration of spontaneous circulation (ROSC) and, despite recent improvements (12) , under 10% survive to hospital discharge (2) . Because most SCA victims are unidentified until their collapse, improved resuscitation would have enormous impact. Potential opportunities include recognizing early warnings, electronic transmittal of event and location data to improve the rapidity and efficacy (13) of first-responders and EMS networks, educational and policy initiatives, and refining the sciences of resuscitation and post-resuscitation care.
SYMPTOMS AND WARNING SIGNS. It is increasingly recognized that SCA is preceded by warning symptoms and signs, which, if promptly recognized, could greatly hasten first response. SCA is often preceded by a nonspecific physician encounter days or weeks before the event (14) . However, until recently, immediately antecedent events were undefined due to difficulties in collecting data at an arrest. Müller et al. (7) dispatched physicians with SCA emergency teams in Germany to interview survivors or bystanders for antecedent events or symptoms. They concluded that SCA is "not as sudden as typically defined." Three-quarters of victims had recognizable symptoms including angina pectoris and dyspnea ( Table 1 ) of which two-thirds lasted 1 h or longer (7) of median duration 50 min in patients with asystole, 20 min before pulseless electrical activity (PEA), and 30 min before ventricular fibrillation (VF) (7) . In the Oregon-SUDS study (Oregon Sudden Unexpected Death Study), symptoms preceded SCA in one-half of victims, yet only 21% contacted EMS (15) .
Those who did were more likely to have a witnessed arrest, receive cardiopulmonary resuscitation (CPR), have a shockable rhythm, and ultimately survive (32.1% vs. 6.0%) (15) . This favorable chain of survival was more likely in patients alerted to symptoms that were recognizable, such as continuous chest pain or who had a prior cardiac history. Other studies reiterate these themes (10) . Symptom awareness is thus likely central to the emerging concept of "near-term prevention" of SCA (16) to bring the window for intervention forward in time.
IMPROVED RESUSCITATION ALERT SYSTEMS. Because symptoms preceding SCA are often overlooked (15) , there is a need for improved early-alert systems for symptoms or potentially signs of SCA. Public education is key and should include traditional efforts, focus groups, and social media. Emerging digital technologies may be helpful. Using a smartphone software application (app) that transmits event and location data, lay responders were able to reach 58% of SCA victims, and initiate CPR before EMS arrival in 27% of cases (17 important, but existing resources should also be optimally deployed. In a real-world study of AED availability in Toronto, Canada, Sun et al. (23) found that one-half of AEDs closest to the location of an SCA were located in offices inaccessible to first-responders when needed. One solution for this place-time mismatch would be to locate community AEDs in lock boxes accessed by neighborhood codes. An ongoing community initiative in Progetto, Italy, uses a volunteer network to deliver AEDs to the scene of SCA (24) . Public policy could substantially improve outcomes but must be carefully designed. On one hand, AEDs could be allocated by residential or workplace density, and risk-stratified, taking precautions to cover less populous areas. Placing AEDs add granularity on noncardiac comorbidities, and expand family history into inherited arrhythmia syndromes and less defined heritability.
New at-risk phenotypes may be defined by new analytics, such as unsupervised cluster analysis and supervised machine learning in defined
populations. The precise shapes of these plots remain to be defined in various populations. LVEF ¼ left ventricular ejection fraction;
SCA ¼ sudden cardiac arrest.
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New Concepts in Sudden Cardiac Arrest on police, firetruck, for-hire, or ride-share vehicles would increase availability, but again will require logistical, ethical, and legal discussions.
Rapid-response requires accurate data on AED location, yet this is often obscure. Recent apps provide comprehensive maps of AED locations, which may improve access (25, 26) but have yet to be tested formally.
Technology could incorporate traffic flow or weather at various times to dynamically optimize response.
Other technological innovations reported to improve AED availability include the use of drones to fly AEDs to sites of SCA (27) Cardiac arrest is defined as the sudden unexpected termination of cardiac activity associated with loss of (8) 60 ( Narayan et al.
New Concepts in Sudden Cardiac Arrest One nascent approach classifies SCA along axes of risk ( Figure 1) , attempting to unify known comorbidities ( Table 2 ) and mechanisms ( Tables 1 and 2 . (64) , yet also increase the proportion of deaths due to causes other than to arrhythmias (8) (Figure 3 ). These and other competing mortality risks limit the effectiveness of ICDs. ICD effectiveness could be improved through the use of risk scores allowing targeted ICD use for patients with the highest proportionate risk of arrhythmic death and the greatest potential mortality benefit (65) (Figure 3) .
The next risk group, individuals with preserved LVEF, contributes more SCA events, yet their low incidence makes it difficult to devise actionable An emerging risk stratification strategy for SCA (66) is to quantify risk along concurrent "axes of comorbidity" such as age, coronary ischemia, and DM, for a population or individual. Athletes may have increased risk for SCA; it must be reconciled why short-term exercise is associated with SCA risk, whereas long-term exercise reduces risk. 
New Concepts in Sudden Cardiac Arrest
SCA in competitive athletes is highly publicized yet uncommon, of incidence 0.11 to 33.3 per 100,000 (71) .
Arrhythmogenic ventricular cardiomyopathy is a unique entity where exercise may be pathogenic and acutely trigger an arrhythmia (72) . Other notable atrisk populations include recreational users of drugs (73, 74) , from cocaine to agents such as the antidiarrheal loperamide (75) . Mechanisms for SCA from drugs include overdose, QT prolongation, and torsades de pointes, coronary vasospasm and dissection, accelerated atherosclerotic coronary disease, myocardial infarction, myocarditis, and seizures.
Mechanistically, current models have had modest success in explaining SCA ( Table 3) . ECG-based fluctuations in repolarization (microvolt T-wave alternans) (76), slow ventricular conduction (77), and autonomic imbalance measured by heart rate variability, baroreflex sensitivity, or heart rate turbulence are predictive in some populations (78) , yet may confer only modest value beyond clinical judgment.
Initiatives suggest combining (79) or improving (78) such metrics, but alternative paradigms may be needed for major advances.
NOVEL CARDIOVASCULAR AND NONCARDIOVASCULAR
PHENOTYPES FOR SCA. Possible mechanisms for SCA in Table 3 These studies re-emphasize the need to explore genetic, nongenetic, cardiac, and noncardiac etiologies for SCA at all ages ( Figure 1 ).
Genetics also contributes to SCA in older individuals, in a more complex fashion (97) . In a case control study post-STEMI (98) concerns, yet education of many stakeholders will still be necessary for them to recognize its importance.
One of our greatest challenges in SCA is the difficulty making financial and policy decisions related to screening for SCA. Societies may, on one hand, institute regulations requiring dissemination of AEDs, yet in parallel, find it difficult to reach consensus on requiring an ECG for sports-related screening (112) .
Funding such initiatives will inevitably prove costly, 
CONCLUSIONS
Improvements in managing SCA will require a concerted effort across scientific disciplines, clinician groups and industry to combine technological innovation and rigorous scientific studies, and focused public policy initiatives. Advances can be considered in the categories of improving first response, improving our pathophysiological understanding, and using insights to prevent SCA in at-risk populations and individuals. These initiatives are diverse, and some are more well defined than others. Nevertheless, the enormity of the problem mandates urgent action at scientific, professional and society-wide levels. 
